These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 2538883

  • 1. [Gd-DTPA in the MR diagnosis of pituitary adenomas].
    Steiner E, Wimberger D, Imhof H, Knosp E, Hajek P.
    Rofo; 1989 Mar; 150(3):323-7. PubMed ID: 2538883
    [Abstract] [Full Text] [Related]

  • 2. Gd-DTPA enhanced high resolution MR imaging of pituitary adenomas.
    Steiner E, Imhof H, Knosp E.
    Radiographics; 1989 Jul; 9(4):587-98. PubMed ID: 2756189
    [Abstract] [Full Text] [Related]

  • 3. Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
    Lundin P, Bergström K.
    Acta Radiol; 1992 Jul; 33(4):323-32. PubMed ID: 1633042
    [Abstract] [Full Text] [Related]

  • 4. ACTH secreting pituitary microadenomas disclosed only by gadolinium DTPA enhanced MRI.
    Boleaga B, Fanghänel G, Cortinas L, Valdés E, Vargas E, Velasco F.
    Rev Invest Clin; 1993 Jul; 45(1):37-42. PubMed ID: 8387223
    [Abstract] [Full Text] [Related]

  • 5. MR imaging of pituitary adenomas with sphenoid sinus invasion: characteristic MR findings indicating fibrosis.
    Ishii K, Ikeda H, Takahashi S, Matsumoto K, Ishibashi T, Tazawa S.
    Radiat Med; 1996 Jul; 14(4):173-8. PubMed ID: 8916258
    [Abstract] [Full Text] [Related]

  • 6. Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.
    Dwyer AJ, Frank JA, Doppman JL, Oldfield EH, Hickey AM, Cutler GB, Loriaux DL, Schiable TF.
    Radiology; 1987 May; 163(2):421-6. PubMed ID: 3562821
    [Abstract] [Full Text] [Related]

  • 7. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
    Miki Y, Matsuo M, Nishizawa S, Kuroda Y, Keyaki A, Makita Y, Kawamura J.
    Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
    [Abstract] [Full Text] [Related]

  • 8. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L, Grazioli L, Maroldi R, Matricardi L, Milanesio L.
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [Abstract] [Full Text] [Related]

  • 9. Dynamic MRI with slow injection of contrast material for the diagnosis of pituitary adenoma.
    Hayashi S, Ito K, Shimada M, Tsubuku M, Kaneko I, Kogure T, Kusama K, Nanba T, Senoh A, Tsuchida S.
    Radiat Med; 1995 Apr; 13(4):167-70. PubMed ID: 8539442
    [Abstract] [Full Text] [Related]

  • 10. 3D MRI of the cervical spine: low flip angle FISP vs. Gd-DTPA TurboFLASH in degenerative disk disease.
    Ross JS, Ruggieri PM, Glicklich M, Obuchowski N, Dillinger J, Masaryk TJ, Qu Y, Modic MT.
    J Comput Assist Tomogr; 1993 Apr; 17(1):26-33. PubMed ID: 8419435
    [Abstract] [Full Text] [Related]

  • 11. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C, Kornmesser W, Laniado M, Kaminsky S, Hamm B, Felix R.
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [Abstract] [Full Text] [Related]

  • 12. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.
    Sakamoto Y, Takahashi M, Korogi Y, Bussaka H, Ushio Y.
    Radiology; 1991 Feb; 178(2):441-5. PubMed ID: 1987606
    [Abstract] [Full Text] [Related]

  • 13. Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging.
    Kucharczyk W, Bishop JE, Plewes DB, Keller MA, George S.
    AJR Am J Roentgenol; 1994 Sep; 163(3):671-9. PubMed ID: 8079866
    [Abstract] [Full Text] [Related]

  • 14. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK, Porter BA, Olson DO, Gerlach R, Genton M.
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [Abstract] [Full Text] [Related]

  • 15. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
    Neumann K, Kaminsky S, Gogoll M, Clauss W, Langer M, Felix R.
    Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
    [Abstract] [Full Text] [Related]

  • 16. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P, Montanari N, De Santis M, Pollastri C.
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [Abstract] [Full Text] [Related]

  • 17. [Study of spondylodiscitis with magnetic resonance. Use of gadolinium-DTPA].
    Duca S, Lo Bello G, Bianchi G, Di Paola A.
    Radiol Med; 1993 Nov; 86(5):587-94. PubMed ID: 8272542
    [Abstract] [Full Text] [Related]

  • 18. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
    Nakamura T, Schörner W, Bittner RC, Felix R.
    Neuroradiology; 1988 Nov; 30(6):481-6. PubMed ID: 3226534
    [Abstract] [Full Text] [Related]

  • 19. Benign extraaxial tumors: contrast enhancement with Gd-DTPA.
    Breger RK, Papke RA, Pojunas KW, Haughton VM, Williams AL, Daniels DL.
    Radiology; 1987 May; 163(2):427-9. PubMed ID: 3031727
    [Abstract] [Full Text] [Related]

  • 20. Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
    Finelli DA, Kaufman B.
    Radiology; 1993 Oct; 189(1):205-10. PubMed ID: 8372195
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.